Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03693261 · ClinicalTrials.gov registry record
Epicardial Fat in Coronary Artery Disease
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 43
- Enrollment target
NCT03693261 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 43 participants.
The verdict
NCT03693261 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
We hypothesize that human epicardial fat plays a thermogenic role to the myocardium. We hypothesize that epicardial fat may express genes of brown fat and thyroid function that are down-regulated by the presence of coronary artery disease. Because the postulated metabolic role of the epicardial fat, we also hypothesize that the gene expression of these regulatory thermogenic factors is higher in epicardial than subcutaneous fat This will be a cross-sectional study conducted over a one-year period in patients with or without coronary artery disease who require elective cardiac surgery regardless their participation in the study. Study group will be formed by 50 patients with clinically and angiographically established CAD who will undergo coronary artery bypass graft, as part of their standard medical care. Control group will be formed by 10 subjects, randomly selected, who will undergo cardiac surgery for aortic or mitral valve replacement as part of their standard medical care (these patients have no history, clinical signs of CAD, and show normal coronary arteries on coronary angiography). This will be a cross-sectional study conducted over a one-year period in patients with or without coronary artery disease who require elective cardiac surgery regardless their participation in the study. Adipose tissue will be collected during the cardiac surgery.
Interventions
- PROCEDURE Coronary artery bypass grafting (CABG)
- PROCEDURE Valve replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2011-12-18 |
| Est. Completion | 2019-04-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03693261
The ClinicalTrials.gov registry entry for NCT03693261 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Coronary artery bypass grafting (CABG) is the first listed.
NCT03693261 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03693261 about?
NCT03693261 is a clinical study titled "Epicardial Fat in Coronary Artery Disease". We hypothesize that human epicardial fat plays a thermogenic role to the myocardium. We hypothesize that epicardial fat may express genes of brown fat and thyroid function that are down-regulated by the presence of coronary artery disease. Because the postulated metabolic role of the epicardial fat,...
What is the current status of trial NCT03693261?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2011-12-18. Estimated completion is 2019-04-15.
What interventions are being tested in trial NCT03693261?
The interventions under investigation include: Coronary artery bypass grafting (CABG) (PROCEDURE), Valve replacement (PROCEDURE).
Who is sponsoring clinical trial NCT03693261?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.